InCareNow

Medications offered

As listed on the provider’s own site. Whether a product is FDA-approved or compounded is the single most important distinction here — we explain why.

• GLP-1 weight loss medicationType not stated

What they publish

InCareNow publishes 2 of 12 standard terms. Fields marked “not publicly disclosed” were not stated on the pages we captured, and we have not filled those gaps with assumptions. Compare disclosure across providers

Membership / programme fee

Initial consultation published at $100-$150 (as published)

Medication cost

Medication published at $150-$375/month, with a total of $300-$550/month (as published)

Introductory offer

Not publicly disclosed on the pages we captured.

Insurance

Not publicly disclosed on the pages we captured.

HSA / FSA

Not publicly disclosed on the pages we captured.

Consultation process

Not publicly disclosed on the pages we captured.

Eligibility

Not publicly disclosed on the pages we captured.

Lab work

Not publicly disclosed on the pages we captured.

Pharmacy fulfilment

Not publicly disclosed on the pages we captured.

Shipping

Not publicly disclosed on the pages we captured.

Support services

Not publicly disclosed on the pages we captured.

Cancellation

Not publicly disclosed on the pages we captured.

Refunds

Not publicly disclosed on the pages we captured.

What stands out

• Breaking the total into consultation and medication components is the presentation most of this market avoids, because it makes the real figure visible.
• The $300-$550 total is realistic rather than a best-case headline.
• Use the breakdown as a template for interrogating any provider's single-number pricing.

Questions to ask before you pay

These are things we could not settle from published pages, or that we think are easy to misread. Get answers in writing.

• Establish where in the $300-$550 range you would fall.
• Ask whether labs are additional again.
• Ask whether the medication is FDA-approved or compounded.